Dr. Zev Jordan Gartner's lab at UCSF focuses on understanding how the tiny finger-like structures in the intestine, called villi, are formed and repaired. This is important because healthy villi are essential for absorbing nutrients, and their dysfunction can lead to serious digestive diseases. The lab combines advanced imaging techniques and mouse genetics to study the forces and signals that drive villus growth and branching. Their research could lead to new therapies for gastrointestinal diseases and strategies for tissue regeneration.

Dr. William Degrado's lab at UCSF explores how proteins work by studying their structures and functions. They focus on viral proteins, particularly those found in influenza and coronaviruses, to design new drugs that can block these viruses, especially those that have become resistant to current treatments. The lab also aims to create new proteins that can assist in drug binding and nutrient transport, contributing to advancements in therapeutic developments.

Dr. Jessica Alber's lab focuses on improving early detection methods for Alzheimer's disease using retinal imaging. The research aims to validate non-invasive, cost-effective biomarkers found in the retina that indicate the early stages of Alzheimer's, potentially enabling timely interventions. By combining retinal imaging with advanced brain scans and blood tests, the lab seeks to develop algorithms for population-wide screening that can identify individuals at risk before symptoms appear.

Dr. Benjamin Franklin Voight's lab focuses on understanding how different types of cells in the pancreas work together to regulate blood sugar levels and how their dysfunction can lead to diabetes. They are using advanced techniques to create a detailed map of gene regulation in pancreatic islet cells, with the goal of identifying genetic factors that contribute to diabetes. This work aims to improve patient care and enhance our understanding of diabetes progression.

Dr. Scott A. Waldman's lab focuses on understanding and targeting visceral pain, particularly related to disorders like irritable bowel syndrome and chronic constipation. They study the role of specific intestinal cells and hormones in regulating nerve activity that contributes to pain, with the aim of developing new, more effective pain relief therapies without major side effects. By investigating a novel signaling pathway in the gut, they hope to translate their findings into innovative treatments for patients suffering from chronic visceral pain.

Dr. Haizhen Wang's lab at the Medical University of South Carolina focuses on improving immunotherapy for solid tumors by studying the functions of cyclin D proteins in T cells. The lab investigates how these proteins impact T cell survival and their ability to infiltrate tumors, which are critical for effective cancer treatment. By manipulating cyclin D expression, the research aims to enhance the efficacy of T cell therapies against cancers like melanoma and colorectal cancer.

Dr. Qiming Jane Wang's lab focuses on developing innovative treatments for advanced castration-resistant prostate cancer (aCRPC). The research combines targeted therapies that inhibit specific cancer cell regulators, using nanocarrier technology to deliver these drugs directly to tumors. The aim is to enhance treatment effectiveness while minimizing side effects, which is crucial for improving patient outcomes in aggressive forms of prostate cancer.

Dr. Hongbing Wang's lab focuses on improving cancer treatments, particularly for aggressive types like triple-negative breast cancer. The research aims to enhance the effectiveness of standard chemotherapy drugs while reducing their harmful side effects. By studying how dual activation of specific proteins can improve drug metabolism and decrease toxicity, the lab hopes to develop better therapies for patients suffering from resistant cancers.

Dr. Wenhui Wang's lab focuses on understanding how the body regulates potassium and sodium levels, particularly in the kidneys. The research investigates how specific channels in kidney cells respond to dietary changes in these electrolytes and how this affects overall health, especially in conditions like chronic kidney disease and heart failure. The lab aims to find new ways to treat issues related to abnormal potassium and sodium levels.

Dr. Daniel Watterson's lab at Northwestern University focuses on developing new treatments for Alzheimer's disease by repurposing existing drugs. The lab is currently working on a drug called MW189, which has shown promise in reducing inflammation in the brain, a key factor in Alzheimer's progression. Through their research, they aim to streamline the process of bringing this drug to clinical trials, ultimately helping patients with dementia and related disorders.

Dr. Stephanie W Watts' lab at Michigan State University investigates the role of perivascular adipose tissue (PVAT) in maintaining vascular health. The lab aims to understand how PVAT interacts with blood vessels and influences blood pressure regulation, which is crucial for preventing cardiovascular diseases. The research employs a variety of animal models and innovative techniques to explore how physiological changes impact PVAT function and, ultimately, cardiovascular health.

Dr. Angela Wilks' lab at the University of Maryland Baltimore investigates how the bacterium Pseudomonas aeruginosa, a major cause of infections, acquires iron to survive in hostile environments. The lab focuses on two important heme uptake systems, exploring how these systems regulate bacterial behavior, such as movement and biofilm formation, in response to the availability of heme. The research aims to uncover potential new therapies to combat antibiotic resistance by disrupting these survival pathways.

Dr. Mark A. Lemmon's lab focuses on understanding unique signaling mechanisms used by unusual receptor tyrosine kinases (RTKs) that play critical roles in various human diseases, including cancer and congenital defects. The research aims to uncover how these receptors, particularly those involved in WNT signaling, can function without the traditional activation methods used by most RTKs. This innovative approach may lead to the discovery of new ways to treat conditions linked to these poorly understood receptors.

Dr. Michael S. Wolfe's lab at the University of Kansas focuses on understanding the mechanisms of Alzheimer's disease, particularly how a key enzyme called gamma-secretase processes amyloid precursor proteins. The lab investigates both genetic mutations that lead to familial Alzheimer's disease and broader factors that influence neuron degeneration. By exploring these processes, the team aims to discover new treatment strategies that might benefit individuals suffering from Alzheimer's, especially those with the late-onset form of the disease.

Dr. Ting-Ting Wu's lab at UCLA focuses on developing an innovative vaccine for Kaposi sarcoma-associated herpesvirus (KSHV), a major cause of cancer in certain populations. The lab's research aims to enhance both the antibody and T cell responses to effectively protect against KSHV infections. By creating a vaccine that improves immunity in high-risk groups, the lab aims to reduce the incidence of KSHV-related diseases, particularly in resource-limited settings and among individuals with compromised immune systems.

Dr. Houhui Xia's lab at the University of Rochester studies how different forms of protein phosphatase 1 (PP1) affect brain functions related to memory and learning. They use special mouse models to explore how these proteins impact synapses—the connections between neurons—by examining their roles in processes like synaptic transmission and long-term potentiation. Their findings could lead to new treatment strategies for neurodegenerative diseases.

Dr. Wen Xie's lab focuses on understanding how environmental chemicals affect human health through their interactions with xenobiotic receptors. These receptors help regulate the metabolism of harmful substances in the body, potentially preventing chronic illnesses such as liver disease and neurological disorders. The research aims to uncover the mechanisms behind these interactions and find ways to mitigate their negative effects on health.

Dr. Kevin Xiang Yang's lab at UC Davis focuses on understanding the molecular mechanisms behind heart failure and memory processes in the brain. The lab investigates how receptors and enzymes, such as adrenergic receptors and phosphodiesterases, influence cardiac function and the signaling pathways that regulate gene expression in neurons. The research aims to discover new therapeutic targets that could enhance heart function in heart failure and improve cognitive disorders.

Dr. Hsin-Sheng Yang's lab at the University of Kentucky focuses on understanding the mechanisms behind lung cancer, particularly how certain proteins interact to control tumor growth. The research investigates the role of a tumor suppressor protein called Pdcd4 and its interaction with Rictor, which is involved in cancer cell growth. By exploring these interactions, the lab aims to develop new therapeutic strategies targeting lung cancer, especially forms with elevated levels of Rictor.

Dr. Renee D Read's lab at Emory University is focused on finding new treatments for glioblastoma, which is a very aggressive brain cancer. The lab investigates how certain proteins, YAP and TAZ, contribute to the growth of these tumors and how they can be inhibited using an existing drug called verteporfin. By understanding these mechanisms, the team aims to improve treatment options for patients with glioblastoma and possibly other related cancers.